Dihydroartemisinin/miR-29b combination therapy increases the pro-apoptotic effect of dihydroartemisinin on cholangiocarcinoma cell lines by regulating Mcl-1 expression
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.